Search Results
Nov 20, 2025, 14:40 ET Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility
trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval in the UK. The MAA is currently undergoing review. The Company has also developed DCVax®-Direct for inoperable solid tumor cancers. It
More news about: Northwest Biotherapeutics, Inc.
Nov 18, 2025, 19:56 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of a negative trend vote on the Marketing Authorisation Application (MAA) for blarcamesine following its CHMP oral explanation." On this news, Anavex's stock price fell $2.05 per share, or 35.94%, to
More news about: Pomerantz LLP
Nov 18, 2025, 08:00 ET Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application (MAA) for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details
More news about: Acurx Pharmaceuticals, Inc.
Nov 17, 2025, 13:00 ET Kimpton Reveals the Trending Tastes of 2026
pepe to create bite-sized noshes of beloved classic meals. Lamberto Valdez Lara, Executive Chef at Kimpton Maa-Lai Bangkok, summarizes: "2026 will be the year that packs a 'crunch'. Chefs are layering textures to create dynamic dishes that turn techniques
More news about: IHG Hotels & Resorts
Nov 13, 2025, 16:05 ET Precigen Reports Third Quarter 2025 Financial Results and Business Updates
quality of life. Geographic expansion: The Company submitted a Marketing Authorization Application (MAA) for zopapogene imadenovec for the treatment of adults with RRP to the European Medicines Agency (EMA) in November 2025.
More news about: Precigen, Inc.
Nov 12, 2025, 07:01 ET Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application (MAA) for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details
More news about: Acurx Pharmaceuticals, Inc.
Nov 10, 2025, 08:00 ET Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens
advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application (MAA) for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details
More news about: Acurx Pharmaceuticals, Inc.
Nov 04, 2025, 16:05 ET Cryoport Reports Third Quarter 2025 Financial Results
In Q3 2025, 4 Biologics License Applications (BLA) / Marketing Authorization Applications (MAA) filings occurred. Post quarter-end, 3 additional BLA filings occurred. During the quarter, Cryoport's customer ExCellThera received conditional marketing
More news about: Cryoport, Inc.
Nov 03, 2025, 16:45 ET MAA Announces Pricing of Senior Unsecured Notes Offering
GERMANTOWN, Tenn., Nov. 3, 2025 /PRNewswire/ -- Mid-America Apartment Communities, Inc., ("MAA") (NYSE: MAA) today announced that its operating partnership, Mid-America Apartments, L.P. ("MAALP"), priced a $400,000,000 offering of MAALP's 4.650% senior
More news about: MAA
Oct 29, 2025, 16:15 ET MAA REPORTS THIRD QUARTER 2025 RESULTS
During the third quarter of 2025, MAA acquired a stabilized and newly built 318-unit multifamily apartment community located in the Kansas City market. During the third quarter of 2025, MAA completed the development of MAA Nixie located in the Raleigh, North Carolina
More news about: MAA
Oct 28, 2025, 08:00 ET Bergdorf Goodman Debuts The Bergdorf Soirée Holiday Campaign
tradition that has defined Bergdorf Goodman for generations, bringing together fashion, fantasy and the inimitable energy of the city," said Kristin Maa, Chief Marketing Officer, Saks Global. "Our campaign captures an inspirational world where extraordinary people and design come together in a way
More news about: Bergdorf Goodman
Oct 28, 2025, 08:00 ET Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference
advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application (MAA) for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details
More news about: Acurx Pharmaceuticals, Inc.
Oct 27, 2025, 08:00 ET Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application (MAA) for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details
More news about: Acurx Pharmaceuticals, Inc.
Oct 24, 2025, 12:30 ET Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval in the UK. The MAA is currently undergoing review. The Company has also developed DCVax®-Direct for inoperable solid tumor cancers. It
More news about: Northwest Biotherapeutics, Inc.
Oct 24, 2025, 12:03 ET Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
trial of DCVax-L for GBM, presented the results in scientific meetings, published the results in JAMA Oncology and submitted a MAA for commercial approval in the UK. The MAA is currently undergoing review. The Company has also developed DCVax®-Direct for inoperable solid tumor cancers. It
More news about: Northwest Biotherapeutics, Inc.
Oct 22, 2025, 09:00 ET Neiman Marcus Reveals the Highly Anticipated 2025 Fantasy Gifts
Marcus. "The Perfect Gift campaign captures the spirit of the season through the lens of fantasy and delight," said Kristin Maa, Chief Marketing Officer, Saks Global. "From remarkable gifts to curated explorations of holiday style, our campaign invites customers into an experience
More news about: Neiman Marcus
Oct 17, 2025, 06:12 ET Weekly Recap: 13 Consumer Press Releases You Need to See
"Saks Fifth Avenue is defining the season with customer connectivity and meaningful memories at the core of our approach," said Kristin Maa, Chief Marketing Officer, Saks Global. "Holiday Your Way inspires customers to embrace their individual style for every occasion and invites them on
More news about: PR Newswire
Oct 14, 2025, 08:14 ET Oracle Adds New Database Capabilities and Partner Program to Oracle Database@AWS
Autonomous AI Database resources via Terraform. Validated Oracle Maximum Availability Architecture (MAA): Helps ensure customers are protected from server and regional outages with minimal downtime and zero data loss. Certified to
More news about: Oracle
Oct 14, 2025, 08:00 ET Saks Fifth Avenue Unveils Holiday Your Way Campaign to Celebrate the Magic of the Holidays
"Saks Fifth Avenue is defining the season with customer connectivity and meaningful memories at the core of our approach," said Kristin Maa, Chief Marketing Officer, Saks Global. "Holiday Your Way inspires customers to embrace their individual style for every occasion and invites
More news about: Saks
Oct 09, 2025, 16:15 ET MAA Announces Date of Third Quarter Earnings Release, Conference Call
Germantown, Tenn., Oct. 9, 2025 /PRNewswire/ -- MAA (NYSE: MAA) announced today that the Company expects to release its third quarter 2025 results on Wednesday, October 29, 2025, after market close and will
More news about: MAA
Oct 02, 2025, 17:31 ET Graves' Orbitopathy Market to Exhibit Growth at a CAGR of 19.8% During the Forecast Period (2025-2034) | DelveInsight
70% of patients maintained a proptosis response at Week 52. Regulatory filings include a planned US BLA submission in 2H 2025 and an anticipated EU MAA submission in 1H 2026, with a US launch targeted for 2H 2026. The FDA granted Breakthrough Therapy Designation in May 2025 due to the rapid response
More news about: DelveInsight Business Research, LLP
Sep 30, 2025, 07:30 ET Acurx Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. difficile Infection
FDA are aligned with its clinical trial program in the adult population along with clearly defined requirements for the regulatory pathway to an EU MAA and a U.S. NDA In addition to receiving this positive EMA opinion, Acurx will proceed with its integrated PIP submission to
More news about: Acurx Pharmaceuticals, Inc.
Sep 30, 2025, 07:30 ET Nuveen Private Equity Impact Acquires Majority Interest in Ally Energy Solutions
growth in electrification, data centers, and advanced manufacturing is driving unprecedented demand for power and electrical services," said Ted Maa, Managing Director of Private Equity Impact Investing at Nuveen. "Ally's impressive results and growth to-date align well with our goal of providing
More news about: Nuveen
Sep 23, 2025, 16:15 ET MAA Announces Quarterly Common Dividend
that is expected to be made on October 29, 2025. About MAAMAA is a self-administered real estate investment trust (REIT) and member of the S&P 500. MAA owns or has ownership interest in apartment communities primarily throughout the Southeast, Southwest
More news about: MAA
Sep 23, 2025, 10:01 ET India Data Center Market to Reach US$ 24.78 Billion by 2033 as Investments Accelerate | Astute Analytica
additional 1.29 GW in the planning stages. Specific projects showcasing this momentum include Digital Connexion's flagship 20 MW greenfield data center, MAA10, located in Chennai. By 2025, India will house approximately 121 operational
More news about: Astute Analytica